Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Sponsor: The First Affiliated Hospital of Soochow University
Summary
The purpose of this study is to assess the efficacy and safety in the real-world settings of glofitamab in combination with salvage therapy among Chinese adult patients with relapsed or refractory B-cell non-hodgkin lymphoma.
Official title: A Prospective, Observational Study to Explore the Efficacy and Safety of Salvage Therapy With Glofitamab in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2024-06-01
Completion Date
2026-06-01
Last Updated
2024-07-11
Healthy Volunteers
No
Conditions
Interventions
Glofitamab
Glofitamab will be administered at the discretion of the physician per local clinical practice and local labeling
Locations (1)
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China